Infectious Diagnostics Rapid & Point of Care Tests Pipeline Review, 2015
Summary
GlobalData's Medical Devices sector report, Infectious Diagnostics Rapid & Point of Care Tests Pipeline Review, 2015 provides an overview of Infectious Diagnostics Rapid & Point of Care Tests currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Infectious Diagnostics Rapid & Point of Care Tests pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Infectious Diagnostics Rapid & Point of Care Tests under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Infectious Diagnostics Rapid & Point of Care Tests and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to buy
The report enables you to
Formulate significant competitor information, analysis, and insights to improve R & D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Infectious Diagnostics Rapid & Point of Care Tests under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the products current stage of development, territory and estimated launch date
Table Of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 13
2 Introduction 14
2.1 Infectious Diagnostics Rapid & Point of Care Tests Overview 14
3 Products under Development 15
3.1 Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Stage of Development 15
3.2 Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Segment 16
3.3 Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Territory 17
3.4 Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Regulatory Path 19
3.5 Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Estimated Approval Date 20
4 Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products under Development by Companies 21
4.1 Infectious Diagnostics Rapid & Point of Care Tests Companies - Pipeline Products by Stage of Development 21
4.2 Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Stage of Development 24
5 Infectious Diagnostics Rapid & Point of Care Tests Companies and Product Overview 29
5.1 A&B Professional di Barsali Brunella Company Overview 29
5.1.1 A&B Professional di Barsali Brunella Pipeline Products & Ongoing Clinical Trials Overview 29
5.2 Akers Biosciences, Inc. Company Overview 30
5.2.1 Akers Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.3 Analyticon Biotechnologies AG Company Overview 34
5.3.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 34
5.4 Aseptika Ltd Company Overview 36
5.4.1 Aseptika Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
5.5 Atomo Diagnostics Pty Limited Company Overview 37
5.5.1 Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 37
5.6 Autoimmune Technologies, LLC Company Overview 39
5.6.1 Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 39
5.7 BACTERIOSCAN LTD. Company Overview 40
5.7.1 BACTERIOSCAN LTD. Pipeline Products & Ongoing Clinical Trials Overview 40
5.8 Biocartis SA Company Overview 41
5.8.1 Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview 41
5.9 BioFire Diagnostics, Inc. Company Overview 42
5.9.1 BioFire Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.10 Biotech Consortium India Limited Company Overview 43
5.10.1 Biotech Consortium India Limited Pipeline Products & Ongoing Clinical Trials Overview 43
5.11 Calypte Biomedical Corporation Company Overview 47
5.11.1 Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview 47
5.12 Canon U.S.A., Inc. Company Overview 50
5.12.1 Canon U.S.A., Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.13 Cepheid Company Overview 51
5.13.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 51
5.14 Coris BioConcept Company Overview 63
5.14.1 Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview 63
5.15 Denka Seiken Co., Ltd. Company Overview 64
5.15.1 Denka Seiken Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
5.16 Diagnostics for the Real World (Europe) Ltd. Company Overview 65
5.16.1 Diagnostics for the Real World (Europe) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 65
5.17 DIESSE Diagnostica Senese S.p.A. Company Overview 66
5.17.1 DIESSE Diagnostica Senese S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 66
5.18 First Light Biosciences, Inc. Company Overview 67
5.18.1 First Light Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.19 Foundation for Innovative New Diagnostics Company Overview 68
5.19.1 Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 68
5.20 Genalyte, Inc. Company Overview 76
5.20.1 Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
5.21 GeneFluidics Inc. Company Overview 77
5.21.1 GeneFluidics Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.22 Great Basin Corporation Company Overview 79
5.22.1 Great Basin Corporation Pipeline Products & Ongoing Clinical Trials Overview 79
5.23 Hema Diagnostic Systems, LLC Company Overview 80
5.23.1 Hema Diagnostic Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 80
5.24 Immunexpress Pty Ltd Company Overview 81
5.24.1 Immunexpress Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 81
5.25 ImmunoScience, Inc. Company Overview 82
5.25.1 ImmunoScience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
5.26 InBios International, Inc. Company Overview 88
5.26.1 InBios International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
5.27 Infectious Disease Research Institute Company Overview 91
5.27.1 Infectious Disease Research Institute Pipeline Products & Ongoing Clinical Trials Overview 91
5.28 Innova Biotechnology Co., Ltd. Company Overview 92
5.28.1 Innova Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 92
5.29 Insilixa, Inc. Company Overview 96
5.29.1 Insilixa, Inc. Pipeline Products & Ongoing Clinical Trials Overview 96
5.30 Institut de Recherche pour le Developpement Company Overview 98
5.30.1 Institut de Recherche pour le Developpement Pipeline Products & Ongoing Clinical Trials Overview 98
5.31 Institut Pasteur Company Overview 101
5.31.1 Institut Pasteur Pipeline Products & Ongoing Clinical Trials Overview 101
5.32 Integrated DNA Technologies, Inc. Company Overview 102
5.32.1 Integrated DNA Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 102
5.33 James Cook University Company Overview 103
5.33.1 James Cook University Pipeline Products & Ongoing Clinical Trials Overview 103
5.34 Labsystems Diagnostics Oy Company Overview 104
5.34.1 Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 104
5.35 Leiden University Company Overview 107
5.35.1 Leiden University Pipeline Products & Ongoing Clinical Trials Overview 107
5.36 Life Technologies Corporation Company Overview 108
5.36.1 Life Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 108
5.37 Lucigen Corporation Company Overview 109
5.37.1 Lucigen Corporation Pipeline Products & Ongoing Clinical Trials Overview 109
5.38 Meru University of Science & Technology Company Overview 110
5.38.1 Meru University of Science & Technology Pipeline Products & Ongoing Clinical Trials Overview 110
5.39 Micronics, Inc. (of Sony Group) Company Overview 111
5.39.1 Micronics, Inc. (of Sony Group) Pipeline Products & Ongoing Clinical Trials Overview 111
5.40 NexGen Arrays Company Overview 116
5.40.1 NexGen Arrays Pipeline Products & Ongoing Clinical Trials Overview 116
5.41 NOWDiagnostics Company Overview 117
5.41.1 NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 117
5.42 OptiCul Diagnostics Ltd. Company Overview 132
5.42.1 OptiCul Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 132
5.43 PrimerDesign Limited Company Overview 133
5.43.1 PrimerDesign Limited Pipeline Products & Ongoing Clinical Trials Overview 133
5.44 Protein Advances Inc. Company Overview 134
5.44.1 Protein Advances Inc. Pipeline Products & Ongoing Clinical Trials Overview 134
5.45 Quidel Corporation Company Overview 136
5.45.1 Quidel Corporation Pipeline Products & Ongoing Clinical Trials Overview 136
5.46 Quotient Limited Company Overview 140
5.46.1 Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview 140
5.47 Randox Laboratories Limited Company Overview 142
5.47.1 Randox Laboratories Limited Pipeline Products & Ongoing Clinical Trials Overview 142
5.48 Rockefeller University Company Overview 143
5.48.1 Rockefeller University Pipeline Products & Ongoing Clinical Trials Overview 143
5.49 Sedia Biosciences Corporation Company Overview 144
5.49.1 Sedia Biosciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 144
5.50 Sight Diagnostics Ltd. Company Overview 145
5.50.1 Sight Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 145
5.51 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 146
5.51.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 146
5.52 Standard Diagnostics, Inc. Company Overview 147
5.52.1 Standard Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 147
5.53 The Johns Hopkins University Company Overview 149
5.53.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 149
5.54 U.S. Army Medical Research Institute of Infectious Diseases Company Overview 151
5.54.1 U.S. Army Medical Research Institute of Infectious Diseases Pipeline Products & Ongoing Clinical Trials Overview 151
5.55 University of California, Berkeley Company Overview 152
5.55.1 University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview 152
5.56 University of California, Irvine Company Overview 154
5.56.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 154
5.57 University of Edinburgh Company Overview 156
5.57.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 156
5.58 University of Nevada, Reno Company Overview 157
5.58.1 University of Nevada, Reno Pipeline Products & Ongoing Clinical Trials Overview 157
5.59 University of Oxford Company Overview 163
5.59.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 163
5.60 University of Virginia Company Overview 164
5.60.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 164
5.61 Vircell S.L Company Overview 165
5.61.1 Vircell S.L Pipeline Products & Ongoing Clinical Trials Overview 165
5.62 Wholehealth Products, Inc. Company Overview 170
5.62.1 Wholehealth Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 170
5.63 Yale University Company Overview 171
5.63.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 171
5.64 Yeda Research and Development Company Ltd. Company Overview 172
5.64.1 Yeda Research and Development Company Ltd. Pipeline Products & Ongoing Clinical Trials Overview 172
6 Infectious Diagnostics Rapid & Point of Care Tests- Recent Developments 174
7 Appendix 210
7.1 Methodology 210
7.2 About GlobalData 212
7.3 Contact Us 213
7.4 Disclaimer 213
List Of Tables
1.1 List of Tables
Table 1: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Stage of Development 15
Table 2: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Segment 16
Table 3: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Territory 18
Table 4: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Regulatory Path 19
Table 5: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Estimated Approval Date 20
Table 6: Infectious Diagnostics Rapid & Point of Care Tests Companies - Pipeline Products by Stage of Development 21
Table 7: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Stage of Development 24
Table 8: A&B Professional di Barsali Brunella Pipeline Products & Ongoing Clinical Trials Overview 29
Table 9: Diagnostic Kit - Parasitic Infection - Product Status 29
Table 10: Diagnostic Kit - Parasitic Infection - Product Description 29
Table 11: Akers Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
Table 12: PIFA Hepatitis B - Product Status 31
Table 13: PIFA Hepatitis B - Product Description 31
Table 14: PIFA Hepatitis C - Product Status 32
Table 15: PIFA Hepatitis C - Product Description 32
Table 16: PIFA Syphilis Rapid Assay - Product Status 33
Table 17: PIFA Syphilis Rapid Assay - Product Description 33
Table 18: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 34
Table 19: ASOslide Latex Slide Test - Product Status 35
Table 20: ASOslide Latex Slide Test - Product Description 35
Table 21: Aseptika Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
Table 22: Home-Use Sputum Test - Bacterial Lung Infection - Product Status 36
Table 23: Home-Use Sputum Test - Bacterial Lung Infection - Product Description 36
Table 24: Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 37
Table 25: AtomoRapid - Hepatitis C - Product Status 37
Table 26: AtomoRapid - Hepatitis C - Product Description 37
Table 27: AtomoRapid - Malaria - Product Status 38
Table 28: AtomoRapid - Malaria - Product Description 38
Table 29: Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 39
Table 30: Diagnostic Assay - Ebola Virus - Product Status 39
Table 31: Diagnostic Assay - Ebola Virus - Product Description 39
Table 32: BACTERIOSCAN LTD. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 33: Antibiotic Susceptibility Testing (AST) - Model 3100Dx - Product Status 40
Table 34: Antibiotic Susceptibility Testing (AST) - Model 3100Dx - Product Description 40
Table 35: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview 41
Table 36: Rapid Ebola Virus Triage Test - Product Status 41
Table 37: Rapid Ebola Virus Triage Test - Product Description 41
Table 38: BioFire Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
Table 39: FilmArray Direct Sepsis Panel - Product Status 42
Table 40: FilmArray Direct Sepsis Panel - Product Description 42
Table 41: Biotech Consortium India Limited Pipeline Products & Ongoing Clinical Trials Overview 43
Table 42: Diagnostic Kit - Chlamydia Infection - Product Status 44
Table 43: Diagnostic Kit - Chlamydia Infection - Product Description 44
Table 44: Diagnostic Kit - Hepatitis A - Product Status 45
Table 45: Diagnostic Kit - Hepatitis A - Product Description 45
Table 46: Rotavirus Diagnostic Kit - Product Status 46
Table 47: Rotavirus Diagnostic Kit - Product Description 46
Table 48: Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview 47
Table 49: Aware 2 HIV-1/2 - Product Status 48
Table 50: Aware 2 HIV-1/2 - Product Description 48
Table 51: Aware HIV-1/2 OMT - Product Status 49
Table 52: Aware HIV-1/2 OMT - Product Description 49
Table 53: Canon U.S.A., Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
Table 54: Diagnostic Test Panel - Lyme Disease - Product Status 50
Table 55: Diagnostic Test Panel - Lyme Disease - Product Description 50
Table 56: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 51
Table 57: GeneXpert Omni - Flu/RSV - Product Status 52
Table 58: GeneXpert Omni - Flu/RSV - Product Description 52
Table 59: GeneXpert Omni - HPV - Product Status 53
Table 60: GeneXpert Omni - HPV - Product Description 53
Table 61: GeneXpert Omni - Xpress CT/NG - Product Status 54
Table 62: GeneXpert Omni - Xpress CT/NG - Product Description 54
Table 63: GeneXpert Omni - Xpress Flu/RSV - Product Status 55
Table 64: GeneXpert Omni - Xpress Flu/RSV - Product Description 55
Table 65: GeneXpert Omni - Xpress GBS Ultra - Product Status 56
Table 66: GeneXpert Omni - Xpress GBS Ultra - Product Description 56
Table 67: GeneXpert Omni - Xpress Group A Strep - Product Status 57
Table 68: GeneXpert Omni - Xpress Group A Strep - Product Description 57
Table 69: GeneXpert Omni - Xpress Pertussis - Product Status 58
Table 70: GeneXpert Omni - Xpress Pertussis - Product Description 58
Table 71: GeneXpert Omni - Xpress Vaginitis/Vaginosis - Product Status 59
Table 72: GeneXpert Omni - Xpress Vaginitis/Vaginosis - Product Description 59
Table 73: Xpert HCV Viral Load Assay - Product Status 60
Table 74: Xpert HCV Viral Load Assay - Product Description 60
Table 75: Xpert MTB/RIF Ultra - Product Status 61
Table 76: Xpert MTB/RIF Ultra - Product Description 61
Table 77: Xpert TV - Product Status 62
Table 78: Xpert TV - Product Description 62
Table 79: Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview 63
Table 80: HAT-PCR-Oligochromatographic Dipstick - Product Status 63
Table 81: HAT-PCR-Oligochromatographic Dipstick - Product Description 63
Table 82: Denka Seiken Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
Table 83: QuickNavi - Ebola Rapid Antigen Detection Test Kit - Product Status 64
Table 84: QuickNavi - Ebola Rapid Antigen Detection Test Kit - Product Description 64
Table 85: Diagnostics for the Real World (Europe) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 65
Table 86: SAMBA - HIV-1 RNA Assay - Product Status 65
Table 87: SAMBA - HIV-1 RNA Assay - Product Description 65
Table 88: DIESSE Diagnostica Senese S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 66
Table 89: Rapid Urine Screening Test - Product Status 66
Table 90: Rapid Urine Screening Test - Product Description 66
Table 91: First Light Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
Table 92: MultiPath UTI AST Assay - Product Status 67
Table 93: MultiPath UTI AST Assay - Product Description 67
Table 94: Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 68
Table 95: 2nd Generation Rapid Diagnostic Test - Human African Trypanosomiasis - Product Status 69
Table 96: 2nd Generation Rapid Diagnostic Test - Human African Trypanosomiasis - Product Description 69
Table 97: Antibody Detection Test - Product Status 70
Table 98: Antibody Detection Test - Product Description 70
Table 99: Antigen Detection Test - Human African Trypanosomiasis - Product Status 71
Table 100: Antigen Detection Test - Human African Trypanosomiasis - Product Description 71
Table 101: BART - Malaria - Product Status 71
Table 102: BART - Malaria - Product Description 72
Table 103: Infection Detection Test - P. falciparum - Product Status 72
Table 104: Infection Detection Test - P. falciparum - Product Description 72
Table 105: P. vivax Serology Test - Product Status 73
Table 106: P. vivax Serology Test - Product Description 73
Table 107: Rapid Diagnostic Test - Neoptrin/CXCL13 - Product Status 74
Table 108: Rapid Diagnostic Test - Neoptrin/CXCL13 - Product Description 74
Table 109: Single Format IgM Quantification Test - Product Status 75
Table 110: Single Format IgM Quantification Test - Product Description 75
Table 111: Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
Table 112: Diagnostic Assay - Ebola Virus - Product Status 76
Table 113: Diagnostic Assay - Ebola Virus - Product Description 76
Table 114: GeneFluidics Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
Table 115: BSI PID/AST CentriFluidic System - Product Status 78
Table 116: BSI PID/AST CentriFluidic System - Product Description 78
Table 117: Great Basin Corporation Pipeline Products & Ongoing Clinical Trials Overview 79
Table 118: Rapid Detection Test - Hypervirulent Strains Of Toxigenic C. difficile - Product Status 79
Table 119: Rapid Detection Test - Hypervirulent Strains Of Toxigenic C. difficile - Product Description 79
Table 120: Hema Diagnostic Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 80
Table 121: Rapid 1-2-3 HEMA EXPRESS - Syphilis Assay - Product Status 80
Table 122: Rapid 1-2-3 HEMA EXPRESS - Syphilis Assay - Product Description 80
Table 123: Immunexpress Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 81
Table 124: SeptiCyte PLUS - Product Status 81
Table 125: SeptiCyte PLUS - Product Description 81
List Of Figures
1.2 List of Figures
Figure 1: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Stage of Development 15
Figure 2: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Segment 16
Figure 3: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Territory 17
Figure 4: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Regulatory Path 19
Figure 5: Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Products by Estimated Approval Date 20
